Home Use of Cupping Massage in Chronic Neck Pain (NaSK)
This study has been completed.
Sponsor:
Universität Duisburg-Essen
Information provided by (Responsible Party):
Romy Lauche, Universität Duisburg-Essen
ClinicalTrials.gov Identifier:
NCT01500330
First received: December 22, 2011
Last updated: October 8, 2013
Last verified: October 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this randomized controlled study is to determine the effectiveness of cupping massage as home use for patients with chronic nonspecific neck pain compared to relaxation exercise.
| Condition | Intervention |
|---|---|
|
Neck Pain |
Procedure: cupping massage Procedure: Progressive muscle relaxation |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Randomised Controlled Study on the Effectiveness of Cupping Massage for Home Use in Chronic Neck Pain [Randomisierte Kontrollierte Studie Zur Wirksamkeit Der Schröpfkopfmassage Als Heimanwendung Bei Chronischen Nackenschmerzen] |
Resource links provided by NLM:
Further study details as provided by Universität Duisburg-Essen:
Primary Outcome Measures:
- Pain Intensity [ Time Frame: T2 (84 days) ] [ Designated as safety issue: No ]Pain intensity on a 100mm visual analogue scale
Secondary Outcome Measures:
- Pain diary [ Time Frame: week 12 ] [ Designated as safety issue: No ]Pain intensity on a visual analogue scale
- pain intensity in motion [ Time Frame: T2 (84 days) ] [ Designated as safety issue: No ]Pain intensity induced by flexion, extension, lateral flexion and rotation of the head
- pain quality [ Time Frame: T2 (84 days) ] [ Designated as safety issue: No ]sensory and affective pain quality, questionnaire
- well being [ Time Frame: T2 (84 days) ] [ Designated as safety issue: No ]Well being measured by questionnaire (FEW16)
- Quality of life [ Time Frame: T2 (84 days) ] [ Designated as safety issue: No ]measured by the SF-36
- Stress perception [ Time Frame: T2 (84 days) ] [ Designated as safety issue: No ]Measured by the PSQ20
- Control belief [ Time Frame: T2 (84 days) ] [ Designated as safety issue: No ]measured by the GKÜ (questionnaire on control beliefs)
- Pressure pain threshold [ Time Frame: T2 (84 days) ] [ Designated as safety issue: No ]pressure pain threshold measured with an algometer on predefined muscles and the pain maximum
- Safety [ Time Frame: T2(84 days) ] [ Designated as safety issue: No ]all adverse events are recorded
| Enrollment: | 84 |
| Study Start Date: | January 2012 |
| Study Completion Date: | May 2012 |
| Primary Completion Date: | May 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: cupping massage
12 weeks home use of cupping massage (delivered by the partner or friend) twice a week for 20 minutes
|
Procedure: cupping massage
the upper back is covered in massage oil the cupping glass is drawn along the back muscles
|
|
Active Comparator: control group
progressive muscle relaxation twice a week for 20 minutes
|
Procedure: Progressive muscle relaxation
standardized programme on muscle relaxation according to Jacobson
|
Detailed Description:
see above
Eligibility| Ages Eligible for Study: | 18 Years to 75 Years (Adult, Senior) |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- mean neck pain intensity 45mm
- neck pain for at least 3 months
- age 18-75
- partner or friend for the application of the massage
Exclusion Criteria:
- specific neck pain due to trauma, neurological disorder, prolapse, operation, cancer
- severe deformity of the spine
- skin disease, allergy on the neck area
- hemophilia, anticoagulation, antiplatelet disorder
- severe psychiatric disorder
- severe comorbidity
- regular intake of opiates and corticosteroids >10mg prednisolon
- pregnancy
- participation in other clinical trials
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01500330
Please refer to this study by its ClinicalTrials.gov identifier: NCT01500330
Locations
| Germany | |
| Klinik für Naturheilkunde | |
| Essen, Germany | |
Sponsors and Collaborators
Universität Duisburg-Essen
Investigators
| Principal Investigator: | Thomas Rampp, MD | Chair of Complementary and Integrative Medicine, University Duisburg-Essen, Germany |
More Information
Additional Information:
Publications:
| Responsible Party: | Romy Lauche, Study coordinator, Universität Duisburg-Essen |
| ClinicalTrials.gov Identifier: | NCT01500330 History of Changes |
| Other Study ID Numbers: | NaSK |
| Study First Received: | December 22, 2011 |
| Last Updated: | October 8, 2013 |
| Health Authority: | Germany: Ethics Commission |
Additional relevant MeSH terms:
|
Neck Pain Pain Neurologic Manifestations Nervous System Diseases Signs and Symptoms |
ClinicalTrials.gov processed this record on September 26, 2016